Wound, Ostomy and Continence Nurses Society (WOCN) Practice Exam

What effect does Somatostatin have when used in fistula management?

1. Increases secretions

2. Decreases bowel mobility

3. Reduces gastrointestinal secretions

4. Promotes appetite

The correct answer is: Reduces gastrointestinal secretions

Somatostatin, a hormone produced in the pancreas and the hypothalamus, plays a significant role in regulating various physiological processes, particularly in the gastrointestinal system. When applied in the context of fistula management, somatostatin is known to reduce gastrointestinal secretions. This action is beneficial in cases where excessive secretions can lead to complications or hinder healing. By decreasing the production of digestive enzymes and other secretions from the stomach and intestines, somatostatin effectively minimizes the volume of fluid that may leak from a fistula. This reduction helps to prevent complications such as electrolyte imbalances and enhances the overall management of the condition. Moreover, controlling these secretions can create a more favorable environment for healing and recovery. The other options, while they pertain to gastrointestinal function, do not accurately describe the primary effects of somatostatin in this context. For instance, increasing secretions or promoting appetite does not align with the physiological actions of somatostatin. Additionally, while somatostatin may influence gut motility, its most relevant and clinically significant effect in fistula management is indeed the reduction of gastrointestinal secretions.